- Home
- AMR vs AXSM Comparison
AMR vs AXSM Comparison
Compare AMR & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMR
- AXSM
- Stock Information
- Founded
- AMR 2016
- AXSM 2012
- Country
- AMR United States
- AXSM United States
- Employees
- AMR N/A
- AXSM N/A
- Industry
- AMR Coal Mining
- AXSM Biotechnology: Pharmaceutical Preparations
- Sector
- AMR Energy
- AXSM Health Care
- Exchange
- AMR Nasdaq
- AXSM Nasdaq
- Market Cap
- AMR 1.9B
- AXSM 5.1B
- IPO Year
- AMR N/A
- AXSM 2015
- Fundamental
- Price
- AMR $155.29
- AXSM $116.78
- Analyst Decision
- AMR Buy
- AXSM Strong Buy
- Analyst Count
- AMR 3
- AXSM 17
- Target Price
- AMR $160.50
- AXSM $175.76
- AVG Volume (30 Days)
- AMR 317.5K
- AXSM 591.0K
- Earning Date
- AMR 10-31-2025
- AXSM 11-11-2025
- Dividend Yield
- AMR N/A
- AXSM N/A
- EPS Growth
- AMR N/A
- AXSM N/A
- EPS
- AMR N/A
- AXSM N/A
- Revenue
- AMR $2,371,475,000.00
- AXSM $495,033,000.00
- Revenue This Year
- AMR N/A
- AXSM $64.05
- Revenue Next Year
- AMR $22.30
- AXSM $56.46
- P/E Ratio
- AMR N/A
- AXSM N/A
- Revenue Growth
- AMR N/A
- AXSM 69.83
- 52 Week Low
- AMR $97.41
- AXSM $75.56
- 52 Week High
- AMR $255.04
- AXSM $139.13
- Technical
- Relative Strength Index (RSI)
- AMR 62.21
- AXSM 47.95
- Support Level
- AMR $138.00
- AXSM $123.54
- Resistance Level
- AMR $145.00
- AXSM $130.00
- Average True Range (ATR)
- AMR 5.81
- AXSM 3.66
- MACD
- AMR 0.02
- AXSM -0.95
- Stochastic Oscillator
- AMR 92.25
- AXSM 4.51
About AMR Alpha Metallurgical Resources Inc.
Alpha Metallurgical Resources Inc is a Tennessee-based coal mining company with operations across Virginia and West Virginia. The company's portfolio of mining operations consists of underground mines, surface mines, and coal preparation plants. It produces low-ash metallurgical coal, including High-Vol. A, Mid-Vol., High-Vol. B, and Low-Vol. coal, which is shipped to domestic and international coke and steel producers. The reportable segment of the company is Met. It extracts, processes and markets met and thermal coal from deep and surface mines for sale to steel and coke producers, industrial customers, and electric utilities.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.